Global Infectious Disease Diagnostics Testing Market 2015-2019

感染症診断検査の世界市場:分子診断検査、POC感染症診断検査

◆タイトル:Global Infectious Disease Diagnostics Testing Market 2015-2019
◆商品コード:IRTNTR7387
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年10月14日
◆ページ数:75
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、感染症診断検査の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、感染症診断検査の世界市場規模及び予測、用途別分析、技術別分析、製品別分析、市場シェア、地域別分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

Infectious diseases are disorders caused by micro-organisms such as viruses, bacteria, fungi, and parasites. These diseases can be transmitted from one individual to another through either direct contact or indirect contact. Anti-infective drugs are used to kill (cidal) or stop the growth (static) of infectious agents. Based on the target organism, anti-infective drugs can be categorized into antibacterial, antiviral, antifungal, and antiparasitic. Anti-infective drugs can act via host defense system or can directly target the causative agent. Infectious diseases such as bacterial infections, respiratory diseases, HPV, and HIV are gradually increasing worldwide. For instance, based on the study of WHO global health observatory (GHO) data, it is estimated that in 2013 34-38 million people suffered from HIV infection worldwide. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care. Infectious disease diagnostic tests help in detecting new pathogens and specific pathogens, monitoring response to therapy, assessing prognosis, and determining appropriate treatment.

Technavio’s analysts forecast the global infectious disease diagnostic testing market to grow at a CAGR of 11.48% over the period 2014-2019.

[Covered in this report]

The report covers the present scenario and growth prospects of the global infectious disease diagnostic testing market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of following product categories:
-Molecular diagnostic test
-POC infectious disease diagnostics test

POC infectious disease diagnostics test is classified into the following based on application:
-Respiratory
-HIV
-HAIs
-Sexual health
-Tropical diseases
-Liver

Technavio’s report, Global Infectious Disease Diagnostic Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the global infectious disease diagnostic testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market

[Key regions]

Americas
APAC
EMEA

[Key vendors]

Abbott Diagnostic
Alere
bioMérieux
Diasorin
Roche Diagnostic

[Other prominent vendors]

Beckman Coulter
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories
Cavidi
Cepheid
Corgenix
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
EUROIMMUN
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
J.Mitra
Meridian Bioscience
OraSure Technologies
ORGENTEC Diagnostika
Ortho Clinical Diagnostics
QIAGEN
Quidel
Siemens Healthcare Diagnostics
TECHLAB
Thermo Fisher Scientific
Trinity Biotech

[Market Driver]

Increase in prevalence of infectious diseases
For a full, detailed list, view our report

[Market challenge]

Emerging infectious diseases
For a full, detailed list, view our report

[Market trend]

Advances in technology
For a full, detailed list, view our report

[Key questions answered in this report]

What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

【資料の目次】

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 06: Market segmentation by technology
Molecular diagnostic tests
POC infectious disease diagnostic tests

PART 07: Market segmentation by application
Global POC infectious disease diagnostic testing market by application
Respiratory
HIV
Healthcare-associated infections
Sexual health
Tropical diseases
Liver infections

PART 08: Market segmentation by product
Assay kits and consumables
Instruments
Services

PART 09: Geographical segmentation
Infectious disease diagnostic testing market in Americas
Infectious disease diagnostic testing market in EMEA
Infectious disease diagnostic testing market in APAC

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors

PART 16: Key vendor analysis
Abbott Diagnostics
Alere
bioMérieux
DiaSorin
Roche Diagnostics

PART 17: Appendix
List of abbreviations

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Global infectious disease diagnostic testing market 2014-2019 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global infectious disease diagnostic testing market by technology
Exhibit 05: Global infectious disease molecular diagnostic testing market 2014-2019 ($ billions)
Exhibit 06: Global POC infectious disease diagnostic testing market 2014-2019 ($ billions)
Exhibit 07: Segmentation of global POC infectious disease diagnostic testing market by application 2014
Exhibit 08: Global respiratory POC infectious disease diagnostic testing market 2014-2019 ($ billions)
Exhibit 09: Demographic statistics for HIV 2014
Exhibit 10: Global HIV POC infectious disease diagnostic testing market 2014-2019 ($ billions)
Exhibit 11: Global HAIs POC infectious disease diagnostic testing market 2014-2019 ($ billions)
Exhibit 12: Global sexual health POC infectious disease diagnostic testing market 2014-2019 ($ billions)
Exhibit 13: Global tropical disease POC infectious disease diagnostic testing market 2014-2019 ($ billions)
Exhibit 14: Global liver POC infectious disease diagnostic testing market 2014-2019 ($ billions)
Exhibit 15: Global POC infectious disease diagnostic testing market by application 2014-2019
Exhibit 16: Segmentation of global infectious disease diagnostic testing by product
Exhibit 17: Segmentation of global infectious disease testing market by product 2014
Exhibit 18: Segmentation of global infectious disease diagnostic testing market by geography 2014
Exhibit 19: Segmentation of global infectious disease diagnostic testing market by geography 2019
Exhibit 20: Segmentation of global infectious disease diagnostic testing market by geography 2014-2019
Exhibit 21: Infectious disease diagnostic testing market in Americas 2014-2019 ($ billions)
Exhibit 22: Infectious disease diagnostic testing market in EMEA 2014-2019 ($ billions)
Exhibit 23: Infectious disease diagnostic testing market in APAC 2014-2019 ($ billions)
Exhibit 24: Impact of drivers
Exhibit 25: Impact of drivers and challenges
Exhibit 26: Key takeaways: Abbott Diagnostics
Exhibit 27: Key takeaways: Alere
Exhibit 28: Key takeaways: bioMerieux
Exhibit 29: Key takeaways: DiaSorin
Exhibit 30: Key takeaways: Roche Diagnostics
Exhibit 31: Abbott Diagnostics: Key business offerings
Exhibit 32: Alere: Business segmentation by revenue 2014
Exhibit 33: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 34: Alere: Geographical segmentation comparison by revenue 2013 and 2014 ($ millions)
Exhibit 35: bioMérieux: Applications by technology
Exhibit 36: DiaSorin: Business segmentation by revenue 2014
Exhibit 37: DiaSorin: Business segmentation by revenue 2013 and 2014
Exhibit 38: DiaSorin: Geographical segmentation by revenue 2014
Exhibit 39: Roche Diagnostics: Business segmentation by revenue 2014
Exhibit 40: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 41: Roche Diagnostics: Geographical segmentation by revenue 2014



【掲載企業】

Abbott Diagnostic, Alere, bioMérieux, Diasorin, Roche Diagnostic, Beckman Coulter, Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Cavidi, Cepheid, Corgenix, Diaxonhit, Eiken Chemical, EMD Millipore, Epitope Diagnostic, EUROIMMUN, Gold Standard Diagnostics, Hologic, Immunetics, InBios International, J.Mitra, Meridian Bioscience, OraSure Technologies, ORGENTEC Diagnostika, Ortho Clinical Diagnostics, QIAGEN, Quidel, Siemens Healthcare Diagnostics, TECHLAB, Thermo Fisher Scientific, Trinity Biotech.

【資料のキーワード】

感染症診断、感染症検査、分子診断検査、POC感染症診断検査、感染症検査キット、感染症検査装置、感染症検査サービス、医療機器

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[感染症診断検査の世界市場:分子診断検査、POC感染症診断検査] (Global Infectious Disease Diagnostics Testing Market 2015-2019 / IRTNTR7387)販売に関する免責事項
[感染症診断検査の世界市場:分子診断検査、POC感染症診断検査] (Global Infectious Disease Diagnostics Testing Market 2015-2019 / IRTNTR7387)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆